1. Home
  2. BGSI vs NVCR Comparison

BGSI vs NVCR Comparison

Compare BGSI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boyd Group Services Inc.

BGSI

Boyd Group Services Inc.

N/A

Current Price

$82.00

Market Cap

2.3B

Sector

N/A

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$14.62

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGSI
NVCR
Founded
1990
2000
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
BGSI
NVCR
Price
$82.00
$14.62
Analyst Decision
Buy
Buy
Analyst Count
15
7
Target Price
★ $104.70
$26.86
AVG Volume (30 Days)
24.9K
★ 1.4M
Earning Date
11-11-2026
10-29-2026
Dividend Yield
★ 0.53%
N/A
EPS Growth
N/A
★ 21.79
EPS
★ N/A
N/A
Revenue
N/A
★ $655,353,000.00
Revenue This Year
$27.51
$10.80
Revenue Next Year
$8.35
$10.83
P/E Ratio
$231.07
★ N/A
Revenue Growth
N/A
★ 8.28
52 Week Low
$75.42
$9.82
52 Week High
$183.10
$21.45

Technical Indicators

Market Signals
Indicator
BGSI
NVCR
Relative Strength Index (RSI) 51.10 44.87
Support Level $75.42 $13.33
Resistance Level $91.90 $15.22
Average True Range (ATR) 2.51 0.64
MACD 0.78 0.07
Stochastic Oscillator 73.60 39.43

Price Performance

Historical Comparison
BGSI
NVCR

About BGSI Boyd Group Services Inc.

Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. The Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority. The company has majority of its sales from USA.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: